Horizon Pharma to Present at the Piper Jaffray 25th Annual Healthcare Conference
(firmenpresse) - DEERFIELD, IL -- (Marketwired) -- 11/26/13 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the Piper Jaffray 25th Annual Healthcare Conference on Tuesday, December 3rd, at 1:30 p.m. Eastern Time in New York, NY. Mr. Walbert will provide an overview of the Company and its corporate activities.
The presentation will be webcast live and may be accessed by visiting Horizon's website at . A replay of the webcast will be available for 10 business days.
Horizon Pharma, Inc. is a specialty pharmaceutical company that has developed and is commercializing products to primary care, orthopedic surgeons and rheumatologists. The Company markets DUEXIS and RAYOS/LODOTRA and will market VIMOVO, which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire or in-license additional innovative medicines where it can execute a targeted commercial approach among specific target physicians while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit .
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.11.2013 - 12:30 Uhr
Sprache: Deutsch
News-ID 320341
Anzahl Zeichen: 0
contact information:
Town:
DEERFIELD, IL
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 266 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Horizon Pharma to Present at the Piper Jaffray 25th Annual Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Horizon Pharma (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
